Home » Novartis Stakes Claim on Potential Drugs From Dana-Farber Institute
Novartis Stakes Claim on Potential Drugs From Dana-Farber Institute
Novartis Institutes of BioMedical Research, the Cambridge, Mass.-based R&D unit of Swiss drug giant Novartis, has asserted itself in a lawsuit concerning rights to potentially game-changing drugs for lung cancer discovered at Dana-Farber Cancer Institute in Boston.
Xconomy
Xconomy
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May